In-vitro product performance of fluticasone furoate (FF)/umeclidinium (UMEC)/vilanterol (VI) delivered from a dry powder inhaler (DPI) using the Electronic Lung (EL) to replicate patient inhalation profiles

被引：0

|

作者：

Prime, D. ^{[1
]}

Hamilton, M. ^{[1
]}

Taylor, E. ^{[1
]}

机构：

[1] GlaxoSmithKline Plc, R&d, Drug Prod Design & Dev, Ware SG12 0DP, Herts, England

来源：

PNEUMOLOGIE | 2020年 / 74卷

关键词：

D O I：

10.1055/s-0039-3403161

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

P411

引用

收藏

页码：S44 / S45

页数：2

相关论文

共 4 条

[1] In-vitro product performance of fluticasone furoate (FF)/umeclidinium (UMEC)/vilanterol (VI) delivered from a dry powder inhaler (DPI) using the Electronic Lung (EL) to replicate patient inhalation profiles
Prime, David
Hamilton, Melanie
Taylor, Edward
EUROPEAN RESPIRATORY JOURNAL, 2019, 54
[2] CONSISTENCY OF DOSE DELIVERY OF FLUTICASONE FUROATE (FF)/UMECLIDINIUM (UMEC)/VILANTEROL (VI) ACROSS PATIENT RELEVANT INHALATION FLOW RATES FROM A DRY-POWDER INHALER (DPI)
Prime, David
Hamilton, Melanie
Patmore, Oonagh
CHEST, 2019, 156 (04) : 1786A - 1786A
[3] In-Vitro Delivery Performance Of Umeclidinium And Umeclidinium/vilanterol From A Dry Powder Inhaler Using The Electronic Lung Breathing Simulator To Replicate Inhalation Profiles From Patients With Varying COPD Severity
Hamilton, M.
Prime, D.
Heuscar, M. Bogalo
Pang, C.
Charles, S.
Gillett, B.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
[4] In Vitro Dosing Performance of the ELLIPTA® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™)
Hamilton, Melanie
Leggett, Richard
Pang, Cheng
Charles, Stephen
Gillett, Ben
Prime, David
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2015, 28 (06) : 498 - 506